The joint task force on the management of valvular heart disease of the European Society of cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)

European Journal of Cardio-thoracic Surgery

Volumn 42, Issue 4, 2012, Pages S1-S44

  Vahanian, Alec ^a   Alfieri, Ottavio ^a,b   Andreotti, Felicita ^a   Antunes, Manuel J ^a   Barón Esquivias, Gonzalo ^a   Baumgartner, Helmut ^a   Borger, Michael Andrew ^a   Carrel, Thierry P ^a   De Bonis, Michele ^a   Evangelista, Arturo ^a   Falk, Volkmar ^a   Iung, Bernard ^a   Lancellotti, Patrizio ^a   Pierard, Luc ^a   Price, Susanna ^a   Schäfers, Hans Joachim ^a   Schuler, Gerhard ^a   Stepinska, Janina ^a   Swedberg, Karl ^a   Takkenberg, Johanna ^a   Von Oppell, Ulrich Otto ^a   Windecker, Stephan ^a   Zamorano, Jose Luis ^a   Zembala, Marian ^a   Bax, Jeroen J ^a   Ceconi, Claudio ^a   Dean, Veronica ^a   Deaton, Christi ^a   Fagard, Robert ^a   Funck Brentano, Christian ^a   Hasdai, David ^a   Hoes, Arno ^a   Kirchhof, Paulus ^a   Knuuti, Juhani ^a   Kolh, Philippe ^a   McDonagh, Theresa ^a   Moulin, Cyril ^a   Popescu, Bogdan A ^a   Reiner, Željko ^a   Sechtem, Udo ^a   Sirnes, Per Anton ^a   Tendera, Michal ^a   Torbicki, Adam ^a   Segesser, Ludwig Von ^a   Badano, Luigi P ^a   Bunc, Matjaž ^a   Claeys, Marc J ^a   Drinkovic, Niksa ^a   Filippatos, Gerasimos ^a   Habib, Gilbert ^a   Kappetein, A Pieter ^a   Kassab, Roland ^a   Lip, Gregory Y H ^a   Moat, Neil ^a   Nickenig, Georg ^a   Otto, Catherine M ^a   Pepper, John ^a   Piazza, Nicolo ^a   Pieper, Petronella G ^a   Rosenhek, Raphael ^a   Shuka, Naltin ^a   Schwammenthal, Ehud ^a   Schwitter, Juerg ^a   Mas, Pilar Tornos ^a   Trindade, Pedro T ^a   Walther, Thomas ^a   more..

^a S Raffaele University Hospital ^*

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Aortic stenosis; Mitral regurgitation; Percutaneous valve intervention; Valve disease; Valve surgery

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIBIOTIC AGENT; ANTIVITAMIN K; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACTIVATED PARTIAL THROMBOPLASTIN TIME; ANTIBIOTIC PROPHYLAXIS; AORTIC DISSECTION; AORTIC REGURGITATION; AORTIC STENOSIS; AORTIC VALVE REPLACEMENT; ATHEROSCLEROSIS; ATRIAL FIBRILLATION; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR RISK; CLINICAL DECISION MAKING; CLINICAL EXAMINATION; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS GRAFT; DIAGNOSTIC VALUE; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; ENDOCARDITIS; EXERCISE ELECTROCARDIOGRAPHY; EXERCISE TEST; FLUOROSCOPY; HEART CATHETERIZATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART OUTPUT; HIGH RISK PATIENT; HUMAN; IMAGE QUALITY; INTERNATIONAL NORMALIZED RATIO; LONG TERM SURVIVAL; LUNG ARTERY PRESSURE; LUNG BLOOD FLOW; MARFAN SYNDROME; MITRAL VALVE REGURGITATION; MITRAL VALVE STENOSIS; MULTIDETECTOR COMPUTED TOMOGRAPHY; PRACTICE GUIDELINE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; RADIONUCLIDE VENTRICULOGRAPHY; REVIEW; RHEUMATIC FEVER; RISK ASSESSMENT; SURGICAL MORTALITY; SURGICAL RISK; SYSTOLIC HEART MURMUR; THREE DIMENSIONAL ECHOCARDIOGRAPHY; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSLUMINAL VALVULOPLASTY; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TRICUSPID VALVE REGURGITATION; VALVULAR HEART DISEASE;

EID: 84944151076     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezs455     Document Type: Review

References (241)

1. Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Bärwolf C, Levang OW et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003;24:1231–43.
2. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet 2006;368:1005–11.
3. Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis 2005;5:685–94.
4. Iung B, Cachier A, Baron G, Messika-Zeitoun D, Delahaye F, Tornos P et al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J 2005;26:2714–20.
5. Mirabel M, Iung B, Baron G, Messika-Zeitoun D, Détaint D, Vanoverschelde JL et al. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur Heart J 2007;28:1358–65.
6. Van Geldorp MWA, van Gameren M, Kappetein AP, Arabkhani B, de Groot-de Laat LE, Takkenberg JJ et al. Therapeutic decisions for patients with symptomatic severe aortic stenosis: room for improvement? Eur J Cardiothorac Surg 2009;35:953–7.
7. Bach DS, Awais M, Gurm HS, Kohnstamn S. Failure of guidelines adherence for intervention in patients with severe mitral regurgitation. J Am Coll Cardiol 2009;54:860–5.
8. Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, Filippatos G et al. Guidelines on the management of valvular heart disease: the Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007;28:230–68.
9. Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD et al. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anaesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2008;52:e1–142.
10. Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I et al. Document Reviewers, Vahanian A, Aguilar R, Bongiorni MG, Borger M, Butchart E, Danchin N, Delahaye F, Erbel R, Franzen D, Gould K, Hall R, Hassager C, Kjeldsen K, McManus R, Miró JM, Mokracek A, Rosenhek R, San Román Calvar JA, Seferovic P, Selton-Suty C, Sousa Uva M, Trinchero R, van Camp G. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and by the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J 2009;30:2369–413.
11. Baumgartner H, Bonhoeffer P, De Groot NMS, de Haan F, Deanfield JE, Galie N et al.; Task Force on the Management of Grown-up Congenital Heart Disease of the European Society of Cardiology (ESC). ESC Guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J 2010;31:2915–57.
12. Vahanian A, Iung B, Pierard L, Dion R, Pepper J. Valvular heart disease. In: Camm AJ, Lüscher TF, Serruys PW (eds). The ESC Textbook of Cardiovascular Medicine, 2nd edn. Malden/Oxford/Victoria: Blackwell Publishing Ltd, 2009, 625–70.
13. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K et al.; ESC Committee for Practice Guidelines (CPG), Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S; Document Reviewers, McDonagh T, Sechtem U, Bonet LA, Avraamides P, Ben Lamin HA, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, Nielsen OW, Orn S, Parissis JT, Ponikowski P. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012;33:1787–847.
14. Popescu BA, Andrade MJ, Badano LP, Fox KF, Flachskampf FA, Lancellotti P et al. on behalf of the European Association of Echocardiography, Document Reviewers, Derumeaux G, Kasprzak JD, Roelandt JRTC. Recommendations for training, competence, and quality improvement in echocardiography. Eur J Echocardiogr 2009;10: 893–905.
15. Baumgartner H, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. Eur J Echocardiogr 2009;10: 1–25.
16. Lancellotti P, Tribouilloy C, Hagendorff A, Moura L, Popescu BA, Agricola E et al. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 1: aortic and pulmonary regurgitation (native valve disease). Eur J Echocardiogr 2010;11:223–44.
17. Lancellotti P, Moura L, Pierard LA, Agricola E, Popescu BA, Tribouilloy C et al. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease). Eur J Echocardiogr 2010;11:307–32.
18. Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K et al. Guidelines for the Echocardiographic Assessment of the Right Heart in Adults: A Report from the American Society of Echocardiography endorsed by the European Association of Echocardiography and the Canadian Society of Echocardiography J Am Soc Echocardiogr 2010; 23:685–713.
19. Lang RM, Badano LP, Tsang W, Adams DH, Agricola E, Buck T et al. EAE/ASE recommendations for image acquisition and display using three-dimensional echocardiography. Eur Heart J Cardiovasc Imag 2012; 13:1–46.
20. Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T et al. Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2010;31:2501–55.
21. Picano E, Pibarot P, Lancellotti P, Monin JL, Bonow RO. The emerging role of exercise testing and stress echocardiography in valvular heart disease. J Am Coll Cardiol 2009;54:2251–60.
22. Monin JL, Quéré JP, Monchi M, Petit H, Baleynaud S, Chauvel C et al. Low-gradient aortic stenosis, operative risk stratification and predictors for long-term outcome: a multicenter study using dobutamine stress hemodynamics. Circulation 2003;108:319–24.
23. Cawley PJ, Maki JH, Otto CM. Cardiovascular magnetic resonance imaging for valvular heart disease. Circulation 2009;119:468–78.
24. Cueff C, Serfaty JM, Cimadevilla C, Laissy JP, Himbert D, Tubach F et al. Measurement of aortic valve calcification using multislicemulti-slice computed tomography: correlation with haemodynamic severity of aortic stenosis and clinical implication for patients with low ejection fraction. Heart 2011;97:721–6.
25. Ketelsen D, Fishman EK, Claussen CD, Vogel-Claussen J. Computed tomography evaluation of cardiac valves: a review. Radiol Clin North Am 2010;48:783–97.
26. Kaleschke G, Seifarth H, Kerckhoff G, Reinecke H, Baumgartner H. Imaging decision-making for transfemoral or transapical approach of transcatheter aortic valve implantation. EuroIntervention 2010;6(Suppl G):G20–7.
27. Messika-Zeitoun D, Serfaty JM, Brochet E, Ducrocq G, Lepage L, Detaint D et al. Multimodal assessment of the aortic annulus diameter: implications for transcatheter aortic valve implantation. J Am Coll Cardiol 2010;55:186–94.
28. Plein S, Schulz-Menger J, Almeida A, Mahrholdt H, Rademakers F, Pennell D et al. Training and accreditation in cardiovascular magnetic resonance in Europe: a position statement of the working group on cardiovascular magnetic resonance of the European Society of Cardiology. Eur Heart J, 2011;32:793–8.
29. Steadman CD, Ray S, Ng LL, McCann GP. Natriuretic peptides in common valvular heart disease. J Am Coll Cardiol 2010;55:2034–48.
30. Gerber MA, Baltimore RS, Eaton CB, Gewitz M, Rowley AH, Shulman ST et al. Prevention of rheumatic fever and diagnosis and treatment of acute Streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation 2009;119:1541–51.
31. Rosenhek R, Iung B, Tornos P, Antunes MJ, Prendergast BD, Otto CM et al. ESC Working Group on Valvular Heart Disease Position Paper: assessing the risk of interventions in patients with valvular heart disease. Eur Heart J 2012;33:822–8.
32. The European Association for Cardio-Thoracic Surgery. Fourth EACTS adult cardiac surgical database report 2010. Henley-on-Thames, UK: Dendrite Clinical Systems Ltd, 2010.
33. The Society of Thoracic Surgeons. Adult cardiac surgery database, executive summary, 10 years STS report. http://www.sts.org/sites/default/files/documents/pdf/ndb2010/1stHarvestExecutiveSummary%5B1%5D.pdf.
34. th national adult cardiac surgical database report; demonstrating quality, 2008. Henley-on-Thames, UK: Dendrite Clinical Systems Ltd, 2009.
35. Gummert JF, Funkat A, Beckmann A, Schiller W, Hekmat K, Ernst M et al. Cardiac surgery in Germany during 2009. A report on behalf of the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg 2010;58:379–86.
36. Rankin JS, Hammill BG, Ferguson TB Jr., Glower DD, O'Brien SM, DeLong ER et al. Determinants of operative mortality in valvular heart surgery. J Thorac Cardiovasc Surg 2006;131:547–57.
37. Ambler G, Omar RZ, Royston P, Kinsman R, Keogh BE, Taylor KM. Generic, simple risk stratification model for heart valve surgery. Circulation 2005;112:224–31.
38. van Gameren M, Kappetein AP, Steyerberg EW, Venema AC, Berenschot EA, Hannan EL et al. Do we need separate risk stratification models for hospital mortality after heart valve surgery? Ann Thorac Surg 2008;85:921–30.
39. Parolari A, Pesce LL, Trezzi M, Cavallotti L, Kassem S, Loardi C et al. EuroSCORE performance in valve surgery: a meta-analysis. Ann Thorac Surg 2010;89:787–793, 793.e1–e2.
40. Dewey TM, Brown D, Ryan WH, Herbert MA, Prince SL, Mack MJ. Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement. J Thorac Cardiovasc Surg 2008;135:180–7.
41. Osswald BR, Gegouskov V, Badowski-Zyla D, Tochtermann U, Thomas G, Hagl S et al. Overestimation of aortic valve replacement risk by EuroSCORE: implications for percutaneous valve replacement. Eur Heart J 2009;30:74–80.
42. Lee DH, Buth KJ, Martin BJ, Yip AM, Hirsch GM. Frail patients are at increased risk for mortality and prolonged institutional care after cardiac surgery. Circulation 2010;121:973–8.
43. Lee SJ, Lindquist K, Segal MR, Covinsky KE. Development and validation of a prognostic index for 4-year mortality in older adults. JAMA 2006; 295:801–8.
44. Gammie JS, O'Brien SM, Griffith BP, Ferguson TB, Peterson ED. Influence of hospital procedural volume on care process and mortality for patients undergoing elective surgery for mitral regurgitation. Circulation 2007;115:881–7.
45. Adams DH, Rosenhek R, Falk V. Degenerative mitral valve regurgitation: best practice revolution. Eur Heart J 2010;31:1958–66.
46. Montori VM, Ting HH. Sharing decision making about cardiac surgery: improving the quality of the decision to undergo or forego surgery. Circ Cardiovasc Qual Outcomes 2009;2:519–21.
47. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010;31:2369–429.
48. Enriquez-Sarano M, Tajik AJ. Clinical practice: aortic regurgitation. N Engl J Med 2004;351:1539–46.
49. Pierard LA, Moonen M, Lancellotti P. Valvular regurgitation. In: Zamorano JL, Bax J, Rademakers F, Knuuti J (eds). The ESC textbook of cardiovascular imaging. Springer, 2010, 150–9.
50. Detaint D, Messika-Zeitoun D, Maalouf J, Tribouilloy C, Mahoney DW, Tajik J et al. Quantitative echocardiographic determinants of clinical outcome in asymptomatic patients with aortic regurgitation. JACC. Cardiovascular imaging 2008;1:1–11.
51. Evangelista A, Flachskampf FA, Erbel R, Antonini-Canterin F, Vlachopoulos Ch, Rocchi G et al. Echocardiography in aortic diseases: EAE recommendations for clinical practice. Eur J Echocardiogr 2010; 11;645–58.
52. La Canna G, Maisano F, De Michele L, Grimaldi A, Grassi F, Capritti E et al. Determinants of the degree of functional aortic regurgitation in patients with anatomically normal aortic valve and ascending thoracic aorta aneurysm. Transoesophageal Doppler echocardiography study. Heart 2009;95:130–6.
53. le Polain de Waroux JB, Pouleur AC, Goffinet C, Vancraeynest D, Van Dyck M, Robert A et al. Functional anatomy of aortic regurgitation: accuracy, prediction of surgical repairability, and outcome implications of tranesophageal echocardiography. Circulation 2007;116 (11 suppl): 1264–9.
54. Sambola A, Tornos P, Ferreira-Gonzalez I, Evangelista A. Prognostic value of preoperative indexed end-systolic left ventricle diameter in the outcome after surgery in patients with chronic aortic regurgitation. Am Heart J 2008;155:1114–20.
55. Marciniak A, Sutherland GR, Marciniak M, Claus P, Bijnens B, Jahangiri M. Myocardial deformation abnormalities in patients with aortic regurgitation: a strain rate imaging study. Eur J Echocardiogr 2009;10: 112–9.
56. Goffinet C, Kersten V, Pouleur AC, Le Polain de Waroux JB, Vancraeynest D, Pasquet A et al. Comprehensive assessment of the severity and mechanism of aortic regurgitation using multidetector CT and MR. Eur Radiol 2010;20:326–36.
57. Bonow RO, Lakatos E, Maron BJ, Epstein SE. Serial long-term assessment of the natural history of asymptomatic patients with chronic aortic regurgitation and normal left ventricular systolic function. Circulation 1991;84:1625–35.
58. Klodas E, Enriquez-Sarano M, Tajik AJ, Mullany CJ, Bailey KR, Seward JB. Optimizing timing of surgical correction in patients with severe aortic regurgitation: role of symptoms. J Am Coll Cardiol 1997;30:746–52.
59. Dujardin KS, Enriquez-Sarano M, Schaff HV, Bailey KR, Seward JB, Tajik AJ. Mortality and morbidity of aortic regurgitation in clinical practice. A long-term follow-up study. Circulation 1999;99:1851–7.
60. Jondeau G, Detaint D, Tubach F, Arnoult F, Milleron O, Raoux F et al. Aortic event rate in the Marfan population: a cohort study. Circulation 2012;125:226–32.
61. Judge DP, Dietz HC. Marfan's syndrome. Lancet 2005;366:1965–76.
62. Keane MG, Wiegers SE, Plappert T, Pochettino A, Bavaria JE, Sutton MG. Bicuspid aortic valves are associated with aortic dilatation out of proportion to co-existent valvular lesions. Circulation 2000;102(19 Suppl 3):pIII-35–39.
63. Davies RR, Kaple RK, Mandapati D, Gallo A, Botta DM, Elefteriades JA et al. Natural history of ascending aortic aneurysms in the setting of an unreplaced bicuspid aortic valve. Ann Thorac Surg 2007;83:1338–44.
64. Tzemos N, Therrien J, Yip J, Thanassoulis G, Tremblay S, Jamorski MT et al. Outcomes in adults with bicuspid aortic valves. JAMA 2008;300: 1317–25.
65. Aicher D, Langer F, Lausberg H, Bierbach B, Schäfers HJ. Aortic root remodeling: ten-year experience with 274 patients. J Thorac Cardiovasc Surg 2007;134:909–15.
66. Aicher D, Fries R, Rodionycheva S, Schmidt K, Langer F, Schäfers HJ. Aortic valve repair leads to a low incidence of valve-related complications. Eur J Cardiothorac Surg 2010;37:127–32.
67. Boodhwani M, de Kerchove L, Glineur D, Rubay J, Vanoverschelde JL, Van Dyck M et al. Aortic valve repair with ascending aortic aneurysms: associated lesions and adjunctive techniques. Eur J Cardiothorac Surg 2011;40:424–8.
68. Takkenberg JJ, Klieverik LM, Schoof PH, van Suylen RJ, van Herwerden LA, Zondervan PE et al. The Ross procedure: a systematic review and meta-analysis. Circulation 2009;119:222–8.
69. Tornos MP, Sambola A, Permanyer-Miralda G, Evangelista A, Gomez Z, Soler-Soler J. Long-term outcome of surgically treated aortic regurgitation: influence of guideline adherence toward early surgery. J Am Coll Cardiol 2006;47:1012–7.
70. Klodas E, Enriquez-Sarano M, Tajik AJ, Mullany CJ, Bailey KR, Seward JB. Aortic regurgitation complicated by extreme left ventricular dilatation: long-term outcome after surgical correction. J Am Coll Cardiol 1996;27: 670–7.
71. Chaliki HP, Mohty D, Avierinos J-F, Scott CG, Schaff HV, Tajik AJ et al. Outcomes after aortic valve replacement in patients with severe aortic regurgitation and markedly reduced left ventricular function. Circulation 2002;106:2687–93.
72. Meijboom LJ, Vos FE, Timmermans J, Boers GH, Zwinderman AH, Mulder B. Pregnancy and aortic root growth in the Marfan syndrome: a prospective study. Eur Heart J 2005;26:914–20.
73. Davies RR, Gallo A, Coady MA, Tellides G, Botta DM, Burke B et al. Novel measurement of relative aortic size predicts rupture of thoracic aortic aneurysms. Ann Thorac Surg 2006;81:169–77.
74. Borger MA, Preston M, Ivanov J, Fedak PW, Davierwala P, Armstrong S et al. Should the ascending aorta be replaced more frequently in patients with bicuspid aortic valve disease? J Thorac Cardiovasc Surg 2004;128:677–83.
75. Evangelista A, Tornos P, Sambola A, Permanyer-Miralda G, Soler-Soler J. Long-term vasodilator therapy in patients with severe aortic regurgitation. N Engl J Med 2005;353:1342–9.
76. Minners J, Allgeier M, Gohlke-Baerwolf C, Kienzle RP, Neumann FJ, Jander N. Inconsistencies of echocardiographic criteria for grading of aortic valve stenosis. Eur Heart J 2008;29:1043–8
77. de Filippi CR, Willett DL, Brickner ME, Appleton CP, Yancy CW, Eichhorn EJ et al. Usefulness of dobutamine echocardiography in distinguishing severe from nonsevere valvular aortic stenosis in patients with depressed left ventricular function and low transvalvular gradients. Am J Cardiol 1995;75:191–4.
78. Levy F, Laurent M, Monin JL, Maillet JM, Pasquet A, Le Tourneau T et al. Aortic valve replacement for low-flow/low-gradient aortic stenosis operative risk stratification and long-term outcome: a European multicenter study. J Am Coll Cardiol 2008;51:1466–72.
79. Jander N, Minners J, Holme I, Gerdts E, Boman K, Brudi P et al. Outcome of patients with low-gradient ‘severe’ aortic stenosis and preserved ejection fraction. Circulation 2011;123:887–95.
80. Lancellotti P, Lebois F, Simon M, Tombeux C, Chauvel C, Pierard LA. Prognostic importance of quantitative exercise: Doppler echocardiography in asymptomatic valvular aortic stenosis. Circulation 2005; 112(9 Suppl):pI-377–382.
81. Maréchaux S, Hachicha Z, Bellouin A, Dumesnil JG, Meimoun P, Pasquet A et al. Usefulness of exercise-stress echocardiography for risk stratification of true asymptomatic patients with aortic valve stenosis. Eur Heart J 2010;31:1390–7.
82. Zamorano JL, Badano LP, Bruce C, Chan KL, Gonçalves A, Hahn RT et al. EAE/ASE recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease. Eur Heart J 2011;32:2189–214.
83. Rafique AM, Biner S, Ray I, Forrester JS, Tolstrup K, Siegel RJ. Meta-analysis of prognostic value of stress testing in patients with asymptomatic severe aortic stenosis. Am J Cardiol 2009;104:972–7.
84. Azevedo CF, Nigri M, Higuchi ML, Pomerantzeff PM, Spina GS, Sampaio RO et al. Prognostic significance of myocardial fibrosis quantification by histopathology and magnetic resonance imaging in patients with severe aortic valve disease. J Am Coll Cardiol 2010;56:278–87.
85. Bergler-Klein J, Klaar U, Heger M, Rosenhek R, Mundigler G, Gabriel H et al. Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis. Circulation 2004;109: 2302–8.
86. Monin JL, Lancellotti P, Monchi M, Lim P, Weiss E, Piérard L et al. Circulation 2009;120:69–75.
87. Lancellotti P, Moonen M, Magne J, O'Connor K, Cosyns B, Attena E et al. Prognostic effect of long-axis left ventricular dysfunction and B-type natriuretic peptide levels in asymptomatic aortic stenosis. Am J Cardiol 2010;105:383–8.
88. Otto CM, Burwash IG, Legget ME, Munt BI, Fujioka M, Healy NL et al. Prospective study of asymptomatic valvular aortic stenosis clinical, echocardiographic and exercise predictors of outcome. Circulation 1997;95:2262–70.
89. Rosenhek R, Binder T, Porenta G, Lang I, Christ G, Schemper M et al. Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med 2000;343:611–7.
90. Pellikka PA, Sarano ME, Nishimura RA, Malouf JF, Bailey KR, Scott CG et al. Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation 2005; 111:3290–5.
91. Rosenhek R, Zilberszac R, Schemper M, Czerny M, Mundigler G, Graf S et al. Natural history of very severe aortic stenosis. Circulation 2010; 121:151–6.
92. Cioffi G, Faggiano P, Vizzardi E, Tarantini L, Cramariuc D, Gerdts E et al. Prognostic value of inappropriately high left ventricular mass in asymptomatic severe aortic stenosis. Heart 2011;97:301–7.
93. Das P, Rimington H, Chambers J. Exercise testing to stratify risk in aortic stenosis. Eur Heart J 2005;26:1309–13.
94. Brown JM, O'Brien SM, Wu C, Sikora JAH, Griffith BP, Gammie JS. Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. J Thorac Cardiovasc Surg 2009;137:82–90.
95. El Bardissi AW, Shekar P, Couper GS, Cohn LH. Minimally invasive aortic valve replacement in octogenarian, high-risk, transcatheter aortic valve implantation candidates. J Thorac Cardiovasc Surg 2011;141:328–35.
96. Chukwuemeka A, Borger MA, Ivanov J, Armstrong S, Feindel C, David T. Valve surgery in octogenarians: a safe option with good medium-term results. J Heart Valve Dis 2006;15:191–6.
97. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG et al.; PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011;364: 2187–98.
98. Tissot CM, Attias D, Himbert D, Ducrocq G, Iung B, Dilly MP et al. Reappraisal of percutaneous aortic balloon valvuloplasty as a preliminary treatment strategy in the transcatheter aortic valve implantation era. EuroIntervention 2011;7:49–56.
99. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG et al.; PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010;363:1597–607.
100. Thomas M, Schymik G, Walther Th, Himbert D, Lefèvre Th, Treede H et al., on behalf of the SOURCE Investigators. Thirty-day results of the SAPIEN aortic bioprosthesis European outcome (SOURCE) registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 2010;122:62–9.
101. Piazza N, Grube E, Gerckens U, den Heijer P, Linke A, Luha O et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention 2008;4:242–9.
102. Thomas M, Schymik G, Walther T, Himbert D, Lefèvre T, Treede H et al. One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 2011;124:425–33.
103. Zahn R, Gerckens U, Grube E, Linke A, Sievert H, Eggebrecht H et al.; The German transcatheter aortic valve interventions: registry investigators. Transcatheter aortic valve implantation: first results from a multicentre real-world registry. Eur Heart J 2011;32:198–204.
104. Eltchaninoff H, Prat A, Gilard M, Leguerrier A, Blanchard D, Fournial G et al.; FRANCE Registry Investigators. Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry. Eur Heart J 2011;32:191–7.
105. Tamburino C, Capodanno D, Ramondo A, Petronio AS, Ettori F, Santoro G et al. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation 2011;123:299–308.
106. Rodés-Cabau J, Webb JG, Cheung A, Ye J, Dumont E, Feindel CM et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol 2010;55:1080–90.
107. Buellesfeld L, Gerckens U, Schuler G, Bonan R, Kovac J, Serruys PW et al. Two-year follow-up of patients undergoing transcatheter aortic valve implantation using a self-expanding valve prosthesis. J Am Coll Cardiol 2011;57:1650–7.
108. Gurvitch R, Wood DA, Tay EL, Leipsic J, Ye J, Lichtenstein SV et al. Transcatheter aortic valve implantation: durability of clinical and hemo-dynamic outcomes beyond 3 years in a large patient cohort. Circulation 2010;122:1319–27.
109. Leon MB, Piazza N, Nikolsky E, Blackstone EH, Cutlip DE, Kappetein AP et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Eur Heart J 2011;32:205–17.
110. Tribouilloy C, Lévy F, Rusinaru D, Guéret P, Petit-Eisenmann H, Baleynaud S et al. Outcome after aortic valve replacement for low-flow/low-gradient aortic stenosis without contractile reserve on dobutamine stress echocardiography. J Am Coll Cardiol 2009;53: 1865–73.
111. Brown ML, Pellikka PA, Schaff HV, Scott CG, Mullany CJ, Sundt TM et al. The benefits of early valve replacement in asymptomatic patients with severe aortic stenosis. J Thorac Cardiovasc Surg 2008;135:308–15.
112. Kang DH, Park SJ, Rim JH, Yun SC, Kim DH, Song JM et al. Early surgery versus conventional treatment in asymptomatic very severe aortic stenosis. Circulation 2010;121:1502–9.
113. Vahanian A, Alfieri O, Al-Attar N, Antunes M, Bax J, Cormier B et al. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2008;29:1463–70.
114. Rossebø AB, Pedersen TR, Boman K, Brudi Ph, Chambers JB, Egstrup K et al.; the SEAS Investigators. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med 2008;359:1343–56.
115. Chan KL, Teo K, Dumesnil JG, Ni A, Tam J; ASTRONOMER Investigators. Effect of lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial. Circulation 2010;121: 306–14.
116. Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren WMM et al.; Other experts who contributed to parts of the guidelines:, Cooney MT; ESC Committee for Practice Guidelines (CPG): Bax J, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S; Document Reviewers: Funck-Brentano C, Sirnes PA, Aboyans V, Ezquerra EA, Baigent C, Brotons C, Burell G, Ceriello A, De Sutter J, Deckers J, Del Prato S, Diener HC, Fitzsimons D, Fras Z, Hambrecht R, Jankowski P, Keil U, Kirby M, Larsen ML, Mancia G, Manolis AJ, McMurray J, Pajak A, Parkhomenko A, Rallidis L, Rigo F, Rocha E, Ruilope LM, van der Velde E, Vanuzzo D, Viigimaa M, Volpe M, Wiklund O, Wolpert C. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 2012;33:1635–701.
117. Smith WT 4th, Ferguson TB Jr, Ryan T, Landolfo CK, Peterson ED. Should coronary artery bypass graft surgery patients with mild or moderate aortic stenosis undergo concomitant aortic valve replacement? A decision analysis approach to the surgical dilemma. J Am Coll Cardiol 2004;44:1241–7.
118. Enriquez-Sarano M, Akins CW, Vahanian A. Mitral regurgitation. Lancet 2009;373:1382–94.
119. Russo A, Suri RM, Grigioni F, Roger VL, Oh JK, Mahoney DW et al. Clinical outcome after surgical correction of mitral regurgitation due to papillary muscle rupture. Circulation 2008;118:1528–34.
120. Monin JL, Dehant P, Roiron C, Monchi M, Tabet JY, Clerc P et al. Functional assessment of mitral regurgitation by transthoracic echocardiography using standardized imaging planes: diagnostic accuracy and outcome implications. J Am Coll Cardiol 2005;46:302–9.
121. Salcedo EE, Quaife RA, Seres T, Carroll JD. A framework for systematic characterization of the mitral valve by real-time three-dimensional transesophageal echocardiography. J Am Soc Echocardiogr 2009;22: 1087–99.
122. Messika-Zeitoun D, Johnson BD, Nkomo V, Avierinos JF, Allison TG, Scott C et al. Cardiopulmonary exercise testing determination of functional capacity in mitral regurgitation: physiologic and outcome implications. J Am Coll Cardiol 2006;47:2521–7.
123. Magne J, Lancellotti P, Piérard LA, Exercise-induced changes in degenerative mitral regurgitation. J Am Coll Cardiol 2010;56:300–9.
124. Lancellotti P, Cosyns B, Zacharakis D, Attena E, Van Camp G, Gach O et al. Importance of left ventricular longitudinal function and functional reserve in patients with degenerative mitral regurgitation: assessment by two-dimensional speckle tracking. J Am Soc Echocardiogr 2008;21: 1331–6.
125. Pizarro R, Bazzino OO, Oberti PF, Falconi M, Achilli F, Arias A et al. Prospective validation of the prognostic usefulness of brain natriuretic peptide in asymptomatic patients with chronic severe mitral regurgitation. J Am Coll Cardiol 2009;54:1099–106.
126. Klaar U, Gabriel H, Bergler-Klein J, Pernicka E, Heger M, Mascherbauer J et al. Prognostic value of serial B-type natriuretic peptide measurement in asymptomatic organic mitral regurgitation. Eur J Heart Fail 2011;13:163–9.
127. Haan CK, Cabral CI, Conetta DA, Coombs LP, Edwards FH. Selecting patients with mitral regurgitation and left ventricular dysfunction for isolated mitral valve surgery. Ann Thorac Surg 2004;78:820–5.
128. Enriquez-Sarano M, Tajik AJ, Schaff HV, Orszulak TA, McGoon MD, Bailey KR et al. Echocardiographic prediction of left ventricular function after correction of mitral regurgitation: results and clinical implications. J Am Coll Cardiol 1994;24:1536–43.
129. Enriquez-Sarano M, Avierinos JF, Messika-Zeitoun D, Detaint D, Capps M, Nkomo V et al. Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med 2005;352:875–83.
130. Barbieri A, Bursi F, Grigioni F, Tribouilloy C, Avierinos JF, Michelina HI et al.; Mitral Regurgitation International DAtabase (MIDA) Investigators. Prognostic and therapeutic implications of pulmonary hypertension complicating degenerative mitral regurgitation due to flail leaflet: a multicenter long-term international study. Eur Heart J 2011; 32:751–9.
131. Tribouilloy C, Grigioni F, Avierinos JF, Barbieri A, Rusinaru D, Szymanski C et al.; MIDA Investigators. Survival implication of left ventricular end-systolic diameter in mitral regurgitation due to flail leaflets: a long-term follow-up multicenter study. J Am Coll Cardiol 2009;54:1961–8.
132. Le Tourneau T, Messika-Zeitoun D, Russo A, Detaint D, Topilsky Y, Mahoney DW et al. Impact of left atrial volume on clinical outcome in organic mitral regurgitation. J Am Coll Cardiol 2010;56:570–8.
133. Grigioni F, Tribouilloy C, Avierinos JF, Barbieri A, Ferlito M, Trojette F et al. Outcomes in mitral regurgitation to flail leaflets: a multicenter European study. JACC: Cardiovascular Imaging 2008;1:133–41.
134. David TE, Ivanov J, Armstrong S, Christie D, Rakowski H. A comparison of outcomes of mitral valve repair for degenerative disease with posterior, anterior, and bileaflet prolapse. J Thorac Cardiovasc Surg 2005;130: 1242–9.
135. Gammie JS, Sheng S, Griffith BP, Peterson ED, Rankin JS, O'Brien S et al. Trends in mitral valve surgery in the United States: results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database. Ann Thorac Surg 2009;87:1431–9.
136. Feldman T, Foster E, Glower DD, Kar S, Rinaldi MJ, Fail PS et al.; EVEREST II Investigators. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med 2011;364:1395–406.
137. Franzen O, Baldus S, Rudolph V, Meyer S, Knap M, Koschyk D et al. Acute outcomes of MitraClip therapy for mitral regurgitation in high-surgical-risk patients: emphasis on adverse valve morphology and severe left ventricular dysfunction. Eur Heart J 2010;31:1373–81.
138. Rosenhek R, Rader F, Klaar U, Gabriel H, Krej M, Kalbeck D et al. Outcome of watchful waiting in asymptomatic severe mitral regurgitation. Circulation 2006;113:2238–44.
139. Kang DH, Kim JH, Rim JH, Kim MJ, Yun SC, Song JM et al. Comparison of early surgery versus conventional treatment in asymptomatic severe mitral regurgitation. Circulation 2009;119:797–804.
140. Samad Z, Kaul P, Shaw LK, Glower DD, Velazquez EJ, Douglas PS et al. Impact of early surgery on survival of patients with severe mitral regurgitation. Heart 2011;97:221–4.
141. Piérard LA, Lancellotti P. The role of ischemic mitral regurgitation in the pathogenesis of acute pulmonary edema. N Engl J Med 2004;351: 1627–34.
142. Grigioni F, Enriquez-Sarano, Zehr KJ, Bailey KR, Tajik AJ. Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation 2001;103:1759–64.
143. Lancellotti P, Gérard P, Piérard L. Long term outcome of patients with heart failure and dynamic functional mitral regurgitation. Eur Heart J 2005;26:1528–32.
144. Gisbert A, Soulière V, Denault AY, Bouchard D, Couture P, Pellerin M et al. Dynamic quantitative echocardiographic evaluation of mitral regurgitation in the operating department. J Am Soc Echocardiogr 2006; 19:140–6.
145. Trichon BH, Felker GM, Shaw LK, Cabell CH, O'Connor CM. Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure. Am J Cardiol 2003;91;538–43.
146. McGee EC Jr, Gillinov AM, Blackstone EH, Rajeswaran J, Cohen G, Najam F et al. Recurrent mitral regurgitation after annuloplasty for functional ischemic mitral regurgitation. J Thorac Cardiovasc Surg 2004; 128:916–24.
147. Fattouch K, Sampognaro R, Speziale G, Salardino M, Novo G, Caruso M et al. Impact of moderate ischemic mitral regurgitation after isolated coronary artery bypass grafting. Ann Thorac Surg 2010;90:1187–94.
148. Mihaljevic T, Lam BK, Rajeswaran J, Takagaki M, Lauer MS, Gillinov AM et al. Impact of mitral valve annuloplasty combined with revascularization in patients with functional ischemic mitral regurgitation. J Am Coll Cardiol 2007;49:2191–201.
149. Wu AH, Aaronson KD, Bolling SF, Pagani FD, Welch K, Koelling TM. Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. J Am Coll Cardiol 2005;45:381–7.
150. Fattouch K, Guccione F, Sampognaro S, Panzarella G, Corrado E, Navarra E et al. Efficacy of adding mitral valve restrictive annuloplasty to coronary artery bypass grafting in patients with moderate ischemic mitral valve regurgitation: a randomized trial. J Thorac Cardiovasc Surg 2009;138:278–85.
151. Braun J, Bax JJ, Versteegh MI, Voigt PG, Holman ER, Klautz RJ et al. Preoperative left ventricular dimensions predict reverse remodelling following restrictive mitral annuloplasty in ischaemic mitral regurgitation. Eur J Cardiothorac Surg 2005;27:847–53.
152. Ciarka A, Braun J, Delgado V, Versteegh M, Boersma E, Klautz R et al. Predictors of mitral regurgitation recurrence in patients with heart failure undergoing mitral valve annuloplasty. Am J Cardiol 2010;106: 395–401.
153. Acker MA, Jessup M, Bolling SF, Oh J, Starling RC, Mann DL et al. Mitral valve repair in heart failure: five-year follow-up from the mitral valve replacement stratum of the Acorn randomized trial. J Thorac Cardiovasc Surg 2011;142:569–74.
154. Pu M, Thomas JD, Gillinov MA, Griffin BP, Brunken RC. Importance of ischemic and viable myocardium for patients with chronic ischemic mitral regurgitation and left ventricular dysfunction. Am J Cardiol 2003; 92:862–4.
155. Vassileva CM, Boley T, Markwell S, Hazelrigg S. Meta-analysis of short-term and long-term survival following repair versus replacement for ischemic mitral regurgitation. Eur J Cardiothorac Surg 2011;39: 295–303.
156. Langer F, Kunihara T, Hell K, Schramm R, Schmidt KI, Aicher D et al. Ring+string: successful repair technique for ischemic mitral regurgitation with severe leaflet tethering. Circulation 2009;120(11 Suppl): S85–91.
157. Grossi EA, Patel N, Woo YJ, Goldberg JD, Schwartz CF, Subramanian V et al.; RESTOR-MV Study Group. Outcomes of the RESTOR-MV trial (Randomized Evaluation of a Surgical Treatment for Off-Pump Repair of the Mitral Valve). J Am Coll Cardiol 2010;56:1984–93.
158. Schofer J, Siminiak T, Haude M, Herrman JP, Vainer J, Wu JC et al. Percutaneous mitral annuloplasty for functional mitral regurgitation: results of the CARILLON Mitral Annuloplasty Device European Union Study. Circulation 2009;120:326–33.
159. van Bommel RJ, Marsan NA, Delgado V, Borleffs CJW, van Rijnsoever EPM, Schalij MJ et al. Cardiac resynchronization therapy as a therapeutic option in patients with moderate-severe functional mitral regurgitation and high operative risk. Circulation 2011;124:912–9.
160. Bouleti C, Iung B, Laouénan C, Himbert D, Brochet E, Messika-Zeitoun D et al. Late results of percutaneous mitral commissurotomy up to 20 years. Development and validation of a risk score predicting late functional results from a series of 912 patients. Circulation 2012;125: 2119–27.
161. Wilkins GT, Weyman AE, Abascal VM, Block PC, Palacios IF. Percutaneous balloon dilatation of the mitral valve: an analysis of echocardiographic variables related to outcome and the mechanism of dilatation. Br Heart J 1988;60:299–308.
162. Messika-Zeitoun D, Brochet E, Holmin C, Rosenbaum D, Cormier B, Serfaty JM et al. Three-dimensional evaluation of the mitral valve area and commissural opening before and after percutaneous mitral commissurotomy in patients with mitral stenosis. Eur Heart J 2007;28: 72–9.
163. Chiang CW, Lo SK, Ko YS, Cheng NJ, Lin PJ, Chang CH et al. A prospective study. Ann Intern Med 1998;128:885–9.
164. Iung B, Nicoud-Houel A, Fondard O, Hafid Akoudad, Haghighat T, Brochet E et al. Temporal trends in percutaneous mitral commissurotomy over a 15-year period. Eur Heart J 2004;25:701–7.
165. Varma PK, Theodore S, Neema PK, Ramachandran P, Sivadasanpillai H, Nair KK et al. Emergency surgery after percutaneous transmitral commissurotomy: operative versus echocardiographic findings, mechanisms of complications, and outcomes. J Thorac Cardiovasc Surg 2005;130: 772–6.
166. Ben Farhat M, Ayari M, Maatouk F, Betbout F, Gamra H, Jarra M et al. Percutaneous balloon versus surgical closed and open mitral commissurotomy: seven-year follow-up results of a randomized trial. Circulation 1998;97:245–50.
167. Fawzy ME, Shoukri M, Al Buraiki J, Hassan W, El Widaa H, Kharabsheh S et al. Seventeen years' clinical and echocardiographic follow up of mitral balloon valvuloplasty in 520 patients, and predictors of long-term outcome. J Heart Valve Dis 2007;16:454–60.
168. Kim MJ, Song JK, Song JM, Kang DH, Kim YH, Lee CW et al. Long-term outcomes of significant mitral regurgitation after percutaneous mitral valvuloplasty. Circulation 2006;114:2815–22.
169. Song J-K, Song J-M, Kang D-H, Yun S-C, Park DW, Lee SW et al. Restenosis and adverse clinical events after successful percutaneous mitral valvuloplasty: immediate post-procedural mitral valve area as an important prognosticator. Eur Heart J 2009;30:1254–62.
170. Cruz-Gonzalez I, Sanchez-Ledesma M, Sanchez PL, Martin-Moreiras J, Jneid H, Rengifo-Moreno P et al. Predicting success and long-term outcomes of percutaneous mitral valvuloplasty: a multifactorial score. Am J Med 2009;122:581.e11–19.
171. Antunes MJ, Vieira H, Ferrão de Oliveira J. Open mitral commissurotomy: the 'golden standard'. J Heart Valve Dis 2000;9:472–7.
172. Song JK, Kim MJ, Yun SC, Choo SJ, Song JM, Song H et al. Long-term outcomes of percutaneous mitral balloon valvuloplasty versus open cardiac surgery. J Thorac Cardiovasc Surg 2010;139:103–10.
173. Iung B, Garbarz E, Doutrelant L, Berdah P, Michaud P, Farah B et al. Late results of percutaneous mitral commissurotomy for calcific mitral stenosis. Am J Cardiol 2000;85:1308–14.
174. Keenan NG, Cueff C, Cimidavella C, Brochet E, Lepage L, Detaint D et al. Usefulness of left atrial volume versus diameter to assess thromboembolic risk in mitral stenosis. Am J Cardiol 2010;106:1152–6.
175. Fawzy ME, Hassan W, Shoukri M, Al Sanei A, Hamadanchi A, El Dali A et al. Immediate and long-term results of mitral balloon valvotomy for restenosis following previous surgical or balloon mitral commissurotomy. Am J Cardiol 2005;96:971–5.
176. Kim JB, Ha JW, Kim JS, Shim WH, Kang SM, Ko YG et al. Comparison of long term outcome after mitral valve replacement or repeated balloon valvotomy in patients with restenosis after previous balloon valvotomy. Am J Cardiol 2007;99:1571–4.
177. Song H, Kang DH, Kim JH, Park K-M, Song J-M, Choi K-J et al. Percutaneous mitral valvuloplasty versus surgical treatment in mitral stenosis with severe tricuspid regurgitation. Circulation 2007;116(11 Suppl):1246–50.
178. Colombo T, Russo C, Ciliberto GR, Lanfranconi M, Bruschi G, Agati S et al. Tricuspid regurgitation secondary to mitral valve disease: tricuspid annulus function as guide to tricuspid valve repair. Cardiovas Surg 2001;9:369–77.
179. Dreyfus GD, Corbi PJ, Chan KM, Bahrami T. Secondary tricuspid regurgitation or dilatation: which should be the criteria for surgical repair? Ann Thorac Surg 2005;79:127–32.
180. Van de Veire NR, Braun J, Delgado V, Versteegh MI, Dion RA, Klautz RJ et al. Tricuspid annuloplasty prevents right ventricular dilatation and progression of tricuspid regurgitation in patients with tricuspid annular dilatation undergoing mitral valve repair. J Thorac Cardiovasc Surg 2011;141:1431–9.
181. Fukuda S, Gillinov AM, McCarthy PM, Stewart WJ, Song JM, Kihara T et al. Determinants of recurrent or residual functional tricuspid regurgitation after tricuspid annuloplasty. Circulation 2006;114(1 Suppl): 1582–7.
182. Haddad F, Doyle R, Murphy DJ, Hunt SA. Right ventricular function in cardiovascular disease, part II: pathophysiology, clinical importance, and management of right ventricular failure. Circulation 2008;117: 1717–31.
183. Nath J, Foster E, Heidenreich PA. Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol 2004;43:405–9.
184. Messika-Zeitoun D, Thomson H, Bellamy M, Scott C, Tribouilloy C, Dearani J et al. Medical and surgical outcome of tricuspid regurgitation caused by flail leaflets. J Thorac Cardiovasc Surg 2004;128:296–302.
185. McCarthy PM, Bhudia SK, Rajeswaran J, Hoercher KJ, Lytle BW, Cosgrove DM et al. Tricuspid valve repair: durability and risk factors for failure. J Thorac Cardiovasc Surg 2004;127:674–85.
186. Navia JL, Nowicki ER, Blackstone EH, Brozzi NA, Nento DE, Atik FA et al. Surgical management of secondary tricuspid valve regurgitation: annulus, commissure, or leaflet procedure? J Thorac Cardiovasc Surg 2010;139:1473–82.
187. Tang GH, David TE, Singh SK, Maganti MD, Armstrong S, Borger MA. Tricuspid valve repair with an annuloplasty ring results in improved long-term outcomes. Circulation 2006;114(1 Suppl):I577–81.
188. Dreyfus GD, Raja SG, John Chan KM. Tricuspid leaflet augmentation to address severe tethering in functional tricuspid regurgitation. Eur J Cardiothorac Surg 2008;34:908–10.
189. Chang BC, Lim SH, Yi G, Hong YS, Lee S, Yoo KJ et al. Long-term clinical results of tricuspid valve replacement. Ann Thorac Surg 2006;81: 1317–23.
190. Unger P, Rosenhek R, Dedobbeleer C, Berrebi A, Lancellotti P. Management of multiple valve disease. Heart 2011;97:272–7.
191. Filsoufi F, Anyanwu AC, Salzberg SP, Frankel T, Cohn LH, Adams DH. Long-term outcomes of tricuspid valve replacement in the current era. Ann Thorac Surg 2005;80:845–50.
192. Yeter E, Ozlem K, Kiliç H, Ramazan A, Acikel S. Tricuspid balloon valvuloplasty to treat tricuspid stenosis. J Heart Valve Dis 2010;19:159–60.
193. De Kerchove L, Glineur D, El Khoury G, Noirhomme P. Stentless valves for aortic valve replacement: where do we stand? Curr Opin Cardiol 2007;22:96–130.
194. Smedira NG, Blackstone EH, Roselli EE, Laffey CC, Cosgrove DM. Are allografts the biologic valve of choice for aortic valve replacement in nonelderly patients? Comparison of explantation for structural valve deterioration of allograft and pericardial prostheses. J Thorac Cardiovasc Surg 2006;131:558–64.
195. El-Hamamsy I, Clark L, Stevens LM, Sarang Z, Melina G, Takkenberg JJ et al. Late outcomes following freestyle versus homograft aortic root replacement: results from a prospective randomized trial. J Am Coll Cardiol 2010;55:368–76.
196. Nowicki ER, Pettersson GB, Smedira NG, Roselli EE, Blackstone EH, Lytle BW. Aortic allograft valve reoperation: surgical challenges and patient risks. Ann Thorac Surg 2008;86:761–8.
197. Byrne JG, Rezai K, Sanchez JA, Bernstein RA, Okum E, Leacche M et al. . Surgical Management of Endocarditis: The Society of Thoracic Surgeons Clinical Practice Guideline. Ann Thorac Surg 2011;91:2012–9.
198. El-Hamamsy I, Eryigit Z, Stevens LM, Sarang Z, George R, Clark L et al. Long-term outcomes after autograft versus homograft aortic root replacement in adults with aortic valve disease: a randomised controlled trial. Lancet 2010;376:524–31.
199. Hammermeister K, Sethi GK, Henderson WG, Grover FL, Oprian C, Rahimtoola SH. Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial. J Am Coll Cardiol 2000;36:1152–8.
200. Oxenham H, Bloomfield P, Wheatley DJ, Lee RJ, Cunningham J, Prescott RJ et al. Twenty year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses. Heart 2003;89:715–21.
201. Stassano P, Di Tommaso L, Monaco M, Iorio F, Pepino P, Spampinato N et al. Aortic valve replacement: a prospective randomized evaluation of mechanical versus biological valves in patients ages 55 to 70 years. J Am Coll Cardiol 2009;54:1862–8.
202. Stoica S, Goldsmith K, Demiris N, Punjabi P, Berg G, Sharples L et al. Microsimulation and clinical outcomes analysis support a lower age threshold for use of biological valves. Heart 2010;96:1730–6.
203. Butchart EG, Gohlke-Bärwolf C, Antunes MJ, Tornos P, De Caterina R, Cormier B et al. Recommendations for the management of patients after heart valve surgery. Eur Heart J 2005;26:2463–71.
204. van Geldorp MW, Eric Jamieson WR, Kappetein AP, Ye J, Fradet GJ, Eijkemans MJ et al. Patient outcome after aortic valve replacement with a mechanical or biological prosthesis: weighing lifetime anticoagulant-related event risk against reoperation risk. J Thorac Cardiovasc Surg 2009;137:881–6.
205. Sun JC, Davidson MJ, Lamy A, Eikelboom JW. Antithrombotic management of patients with prosthetic heart valves: current evidence and future trends. Lancet 2009;374:565–76.
206. Herzog CA, Ma JZ, Collins AJ. Long-term survival of dialysis patients in the United States with prosthetic heart valves: should ACC/AHA practice guidelines on valve selection be modified? Circulation 2002;105: 1336–41.
207. Regitz-Zagrosek V, Lundqvist CB, Borghi C, Cifkova R, Ferreira R, Foidart JM et al.; ESC Committee for Practice Guidelines (CPG), Bax J, Auricchio A, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Knuuti J, Kolh P, McDonagh T, Moulin C, Poldermans D, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Torbicki A, Vahanian A, Windecker S; Document Reviewers, Baumgartner H, Deaton C, Aguiar C, Al-Attar N, Garcia AA, Antoniou A, Coman I, Elkayam U, Gomez-Sanchez MA, Gotcheva N, Hilfiker-Kleiner D, Kiss RG, Kitsiou A, Konings KT, Lip GY, Manolis A, Mebaaza A, Mintale I, Morice MC, Mulder BJ, Pasquet A, Price S, Priori SG, Salvador MJ, Shotan A, Silversides CK, Skouby SO, Stein JI, Tornos P, Vejlstrup N, Walker F, Warnes C. ESC Guidelines on the management of cardiovascular diseases during pregnancy: The Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J 2011;32:3147–97.
208. Bleiziffer S, Eichinger WB, Hettich I, Guenzinger R, Ruzicka D, Bauernschmitt R et al. Prediction of valve prosthesis-patient mismatch prior to aortic valve replacement: which is the best method? Heart 2007;93:615–20.
209. Pibarot P, Dumesnil JG. Prosthetic heart valves: selection of the optimal prosthesis and long-term management. Circulation 2009;119:1034–48.
210. Zoghbi WA, Chambers JB, Dumesnil JG, Foster E, Gottdiener JS, Grayburn PA et al. Recommendations for evaluation of prosthetic valves with echocardiography and doppler ultrasound: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Task Force on Prosthetic Valves, developed in conjunction with the American College of Cardiology Cardiovascular Imaging Committee, Cardiac Imaging Committee of the American Heart Association, the European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography and the Canadian Society of Echocardiography, endorsed by the American College of Cardiology Foundation, American Heart Association, European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography, and Canadian Society of Echocardiography. J Am Soc Echocardiogr 2009;22: 975–1014.
211. Symersky P, Budde RP, de Mol BA, Prokop M. Comparison of multidetector-row computed tomography to echocardiography and fluoroscopy for evaluation of patients with mechanical prosthetic valve obstruction. Am J Cardiol 2009;104:1128–34.
212. Salem DN, O'Gara PT, Madias C, Pauker SG. Valvular and structural heart disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133(6 Suppl): p593S–629S.
213. Cannegieter SC, Rosendaal FR, Briët E. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 1994;89:635–41.
214. Nowell J, Wilton E, Markus H, Jahangiri M. Antithrombotic therapy following bioprosthetic aortic valve replacement. Eur J Cardiothorac Surg 2007;31:578–85.
215. Dunning J, Versteegh M, Fabbri A, Pavie A, Kolh P, Lockowandt U et al.; EACTS Audit and Guidelines Committee. Guideline on antiplatelet and anticoagulation management in cardiac surgery. Eur J Cardiothorac Surg 2008;34:73–92.
216. Rivas-Gándara N, Ferreira-González I, Tornos P, Torrents A, Permanyer-Miralda G, Nicolau I et al. Enoxaparin as bridging anticoagulant treatment in cardiac surgery. Heart 2008;94:205–10.
217. Laplace G, Lafitte S, Labèque JN, Perron JM, Baudet E, Deville C et al. Clinical significance of early thrombosis after prosthetic mitral valve replacement: a postoperative monocentric study of 680 patients. J Am Coll Cardiol 2004;43:1283–90.
218. Russo A, Grigioni F, Avierinos JF, Freeman WK, Suri R, Michelena H et al. Thromboembolic complications after surgical correction of mitral regurgitation incidence, predictors, and clinical implications. J Am Coll Cardiol 2008;51:1203–11.
219. Butchart EG, Ionescu A, Payne N, Giddings J, Grunkemeier GL, Fraser AG. A new scoring system to determine thromboembolic risk after heart valve replacement. Circulation 2003;108(Suppl 1):II68–74.
220. Acar J, Iung B, Boissel JP, Samama MM, Michel PL, Teppe JP et al. AREVA: multicenter randomized comparison of low-dose versus standard-dose anticoagulation in patients with mechanical prosthetic heart valves. Circulation 1996;94:2107–12.
221. Hering D, Piper C, Bergemann R, Hillenbach C, Dahm M, Huth C et al. Thromboembolic and bleeding complications following St. Jude Medical valve replacement: results of the German Experience With Low-Intensity Anticoagulation Study. Chest 2005;127:53–9.
222. Koertke H, Zittermann A, Tenderich G, Wagner O, El-Arousy M, Krian A et al. Low-dose oral anticoagulation in patients with mechanical heart valve prostheses: final report from the early self-management anticoagulation trial II. Eur Heart J 2007;28:2479–84.
223. Pernod G, Godiér A, Gozalo C, Tremey B, Sié P; French National Authority for Health. French clinical practice guidelines on the management of patients on vitamin K antagonists in at-risk situations (overdose, risk of bleeding, and active bleeding). Thromb Res 2010;126: e167–74.
224. Turpie AG, Gent M, Laupacis A, Latour Y, Gunstensen J, Basile F et al. A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement. N Engl J Med 1993;329:524–9.
225. Massel D, Little SH. Risks and benefits of adding anti-platelet therapy to warfarin among patients with prosthetic heart valves: a meta-analysis. J Am Coll Cardiol 2001;37:569–78.
226. Laffort P, Roudaut R, Roques X, Lafitte S, Deville C, Bonnet J et al. Early and long-term (one-year) effects of the association of aspirin and oral anticoagulant on thrombi and morbidity after replacement of the mitral valve with the St. Jude medical prosthesis: a clinical and transesophageal echocardiographic study. J Am Coll Cardiol 2000;35:739–46.
227. Poldermans D, Bax JJ, Boersma E, De Hert S, Eeckhout E, Fowkes G et al. Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: the Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and European Society of Anaesthesiology (ESA). Eur Heart J 2009;30:2769–812.
228. Douketis JD, Berger PB, Dunn AS, Jaffer AK, Spyropoulos AC, Becker RC et al. The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133:299S–339S.
229. Francophone society of oral medicine and oral surgery wtcotFsoc. Guidelines for management of patients under antivitamin K treatment in oral surgery. http://www.societechirbuc.com/Recommandations/recommandations_avk_gb.pdf.
230. Ferreira I, Dos L, Tornos P, Nicolau I, Permanyer-Miralda G, Soler-Soler J. Experience with enoxaparin in patients with mechanical heart valves who must withhold acenocumarol. Heart 2003;89:527–30.
231. Pengo V, Cucchini U, Denas G, Erba N, Guazzaloca G, La Rosa L et al.; Italian Federation of Centers for the Diagnosis of Thrombosis and Management of Antithrombotic Therapies (FCSA). Standardized low-molecular-weight heparin bridging regimen in outpatients on oral anticoagulants undergoing invasive procedure or surgery: an inception cohort management study. Circulation 2009;119:2920–27.
232. Tong AT, Roudaut R, Ozkan M, Sagie A, Shahid MS, Pontes Júnior SC et al.; Prosthetic Valve Thrombolysis-Role of Transesophagesophageal Echocardiography (PRO-TEE) Registry Investigators. Transesophagesophageal echocardiography improves risk assessment of thrombolysis of prosthetic valve thrombosis: results of the international PRO-TEE registry. J Am Coll Cardiol 2004;43:77–84.
233. Roudaut R, Lafitte S, Roudaut MF, Reant P, Pillois X, Durrieu-Jaïs C et al. Management of prosthetic heart valve obstruction: fibrinolysis versus surgery. Early results and long-term follow-up in a single-centre study of 263 cases. Early results and long-term follow-up in a single-centre study of 263 cases. Arch Cardiovasc Dis 2009;102:269–77.
234. Roudaut R, Serri K, Lafitte S. Thrombosis of prosthetic heart valves: diagnosis and therapeutic considerations. Heart 2007;93:137–42.
235. Ionescu A, Fraser AG, Butchart EG. Prevalence and clinical significance of incidental paraprosthetic valvar regurgitation: a prospective study using transoesophageal echocardiography. Heart 2003;89: 1316–21.
236. Sorajja P, Cabalka AK, Hagler DJ, Rihal CS. Percutaneous repair of paravalvular prosthetic regurgitation: acute and 30-day outcomes in 115 patients. Circ Cardiovasc Interv 2011;4:314–21.
237. Jaussaud N, Gariboldi V, Giorgi R, Grisoli D, Chalvignac V, Thuny F et al. Risk of reoperation for aortic bioprosthesis dysfunction. J Heart Valve Dis 2009;18:256–61.
238. Webb JG, Wood DA, Ye J, Gurvitch R, Masson JB, Rodés-Cabau J et al. Transcatheter valve-in-valve implantation for failed bioprosthetic heart valves. Circulation 2010;121:1848–57.
239. Piazza N, Bleiziffer S, Brockmann G, Hendrick R, Deutsch M-A, Opitz A et al. Transcatheter aortic valve implantation for failing surgical aortic bioprosthetic valve: from concept to clinical application and evaluation (Part 1). JACC Cardiovasc Interv 2011;4:721–32.
240. Calleja AM, Dommaraju S, Gaddam R, Cha S, Khandheria BK, Chaliki HP. Cardiac risk in patients aged >75 years with asymptomatic, severe aortic stenosis undergoing noncardiac surgery. Am J Cardiol 2010;105: 1159–63.
241. Bradley D, Creswell LL, Hogue CW Jr, Epstein AE, Prystowsky EN, Daoud EG. Pharmacologic prophylaxis: American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery. Chest 2005;128: 39S–47S.